CORT | Corcept TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$80.46
-$0.66 (-0.81%)

Corcept Therapeutics (CORT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
between the two $80.46 vs 50 $111.14 / 200 $74.99
Projection
No cross projected
Test
No active test
Last cross
Golden cross 23 Jun 2026 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $81.12 vs 50 $73.59 / 200 $49.96
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
below both $82.91 vs 50 $106.99 / 200 $104.30
Projection
Death cross projected in 5 bars
Test
No active test
Last cross
Golden cross 6 May 2026 ยท projected 29 bars out

Cross history

21
crosses on record since 2018
11 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Jun 2026Golden steepdaily26 bars outNot tested
6 May 2026Golden4-hour29 bars outNot tested
9 Jan 2026Death moderatedaily6 bars outNot tested
6 Jan 2026Death4-hour29 bars outNot tested
22 Sep 2025Golden4-hour14 bars outโ€”

About CORT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$94.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.